CVI Holdings’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-55,486
| Closed | -$2.35K | – | 303 |
|
|
2023
Q2 | $2.35K | Hold |
55,486
| – | – | ﹤0.01% | 227 |
|
|
2023
Q1 | $1.64K | Buy |
+55,486
| New | +$3.98K | ﹤0.01% | 383 |
|
|
2022
Q4 | – | Sell |
-55,486
| Closed | -$6K | – | 716 |
|
|
2022
Q3 | $6K | Hold |
55,486
| – | – | ﹤0.01% | 703 |
|
|
2022
Q2 | $14K | Hold |
55,486
| – | – | ﹤0.01% | 682 |
|
|
2022
Q1 | $15K | Hold |
55,486
| – | – | ﹤0.01% | 818 |
|
|
2021
Q4 | $12K | Hold |
55,486
| – | – | ﹤0.01% | 925 |
|
|
2021
Q3 | $22K | Sell |
55,486
-2,500
| -4% | -$1.23K | ﹤0.01% | 835 |
|
|
2021
Q2 | $30K | Hold |
57,986
| – | – | ﹤0.01% | 740 |
|
|
2021
Q1 | $50K | Hold |
57,986
| – | – | ﹤0.01% | 553 |
|
|
2020
Q4 | $22K | Hold |
57,986
| – | – | ﹤0.01% | 178 |
|
|
2020
Q3 | $10K | Hold |
57,986
| – | – | ﹤0.01% | 77 |
|
|
2020
Q2 | $12K | Sell |
57,986
-5,300
| -8% | -$1.82K | ﹤0.01% | 64 |
|
|
2020
Q1 | $1K | Hold |
63,286
| – | – | ﹤0.01% | 35 |
|
|
2019
Q4 | $6K | Hold |
63,286
| – | – | 0.01% | 31 |
|
|
2019
Q3 | $6K | Sell |
63,286
-1,000
| -2% | -$482 | 0.01% | 33 |
|
|
2019
Q2 | $14K | Hold |
64,286
| – | – | 0.02% | 54 |
|
|
2019
Q1 | $29K | Hold |
64,286
| – | – | 0.03% | 42 |
|
|
2018
Q4 | $32K | Hold |
64,286
| – | – | 0.07% | 28 |
|
|
2018
Q3 | $47K | Buy |
+64,286
| New | +$38.2K | 0.08% | 31 |
|
CVI Holdings's MDGSW Position: Q3 2023 in Review
CVI Holdings sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q3 2023, closing a stake of 55,486 shares — an estimated $2.35K sold.
CVI Holdings first reported a position in MDGSW in Q3 2018 and held it in 19 quarters. The position peaked at $50K in Q1 2021. 0 funds tracked by Wall St. Rank hold MDGSW as of Q3 2023.
- CVI Holdings reported no remaining Medigus Ltd. Series C Warrant position as of Q3 2023 after selling out during the quarter.
- CVI Holdings sold 55,486 Medigus Ltd. Series C Warrant shares in Q3 2023, an estimated $2.35K.
- CVI Holdings first reported a position in Medigus Ltd. Series C Warrant in Q3 2018 and held it in 19 quarters.
- CVI Holdings's Medigus Ltd. Series C Warrant position peaked at $50K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q3 2023.
Based on CVI Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.